New approach to tumor therapy for inoperable areas of the brain chronic intraparenchymal drug delivery

Benjamin Solomon, Q. Wu, Betty Mae Tyler, L. Sukay, R. Raychaudhuri, F. DiMeco, R. E. Clatterbuck, Alessandro Olivi, M. Guarnieri

Research output: Contribution to journalArticle

Abstract

Because the brainstem has little functional redundancy, diffuse lesions have been regarded as inoperable. To determine whether local drug therapy can prolong survival in a rodent model of a tumor in such eloquent tissue, lethal doses of F98 and 9L tumor cells were injected into the brainstems of Fischer 344 rats. Five days after inoculations, 0.5 mg/ml solutions of carboplatin were infused at 1 μl/h for 7 days. Compared to control groups that survived 13-17 days with F98 tumors and 22-23 days with 9L tumors, animals locally infused with 0.1 mg of carboplatin survived 27-30 days (Prob > Chi Sq = 0.0003), and 32 days (Prob > Chi Sq = 0.01), respectively. Measurements of tissue platinum levels at autopsy suggested that infusions distributed pharmacologically relevant levels of carboplatin through a volume of tissue at least 0.5 cm in diameter. The results suggest that chronic low-flow infusions provide a promising approach to therapy for CNS lesions in tissues considered to be inoperable.

Original languageEnglish (US)
Pages (from-to)151-158
Number of pages8
JournalJournal of Neuro-Oncology
Volume60
Issue number2
DOIs
StatePublished - Nov 1 2002

Fingerprint

Carboplatin
Brain
Pharmaceutical Preparations
Brain Stem
Neoplasms
Inbred F344 Rats
Therapeutics
Platinum
Autopsy
Rodentia
Drug Therapy
Control Groups

Keywords

  • Brainstem tumors
  • Carboplatin
  • CNS cancer
  • Intracranial drug delivery
  • Intraparenchymal therapy

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neuroscience(all)

Cite this

New approach to tumor therapy for inoperable areas of the brain chronic intraparenchymal drug delivery. / Solomon, Benjamin; Wu, Q.; Tyler, Betty Mae; Sukay, L.; Raychaudhuri, R.; DiMeco, F.; Clatterbuck, R. E.; Olivi, Alessandro; Guarnieri, M.

In: Journal of Neuro-Oncology, Vol. 60, No. 2, 01.11.2002, p. 151-158.

Research output: Contribution to journalArticle

Solomon, B, Wu, Q, Tyler, BM, Sukay, L, Raychaudhuri, R, DiMeco, F, Clatterbuck, RE, Olivi, A & Guarnieri, M 2002, 'New approach to tumor therapy for inoperable areas of the brain chronic intraparenchymal drug delivery', Journal of Neuro-Oncology, vol. 60, no. 2, pp. 151-158. https://doi.org/10.1023/A:1020626419269
Solomon, Benjamin ; Wu, Q. ; Tyler, Betty Mae ; Sukay, L. ; Raychaudhuri, R. ; DiMeco, F. ; Clatterbuck, R. E. ; Olivi, Alessandro ; Guarnieri, M. / New approach to tumor therapy for inoperable areas of the brain chronic intraparenchymal drug delivery. In: Journal of Neuro-Oncology. 2002 ; Vol. 60, No. 2. pp. 151-158.
@article{3aedd0ad870a4bd39e4b268a5322aa7a,
title = "New approach to tumor therapy for inoperable areas of the brain chronic intraparenchymal drug delivery",
abstract = "Because the brainstem has little functional redundancy, diffuse lesions have been regarded as inoperable. To determine whether local drug therapy can prolong survival in a rodent model of a tumor in such eloquent tissue, lethal doses of F98 and 9L tumor cells were injected into the brainstems of Fischer 344 rats. Five days after inoculations, 0.5 mg/ml solutions of carboplatin were infused at 1 μl/h for 7 days. Compared to control groups that survived 13-17 days with F98 tumors and 22-23 days with 9L tumors, animals locally infused with 0.1 mg of carboplatin survived 27-30 days (Prob > Chi Sq = 0.0003), and 32 days (Prob > Chi Sq = 0.01), respectively. Measurements of tissue platinum levels at autopsy suggested that infusions distributed pharmacologically relevant levels of carboplatin through a volume of tissue at least 0.5 cm in diameter. The results suggest that chronic low-flow infusions provide a promising approach to therapy for CNS lesions in tissues considered to be inoperable.",
keywords = "Brainstem tumors, Carboplatin, CNS cancer, Intracranial drug delivery, Intraparenchymal therapy",
author = "Benjamin Solomon and Q. Wu and Tyler, {Betty Mae} and L. Sukay and R. Raychaudhuri and F. DiMeco and Clatterbuck, {R. E.} and Alessandro Olivi and M. Guarnieri",
year = "2002",
month = "11",
day = "1",
doi = "10.1023/A:1020626419269",
language = "English (US)",
volume = "60",
pages = "151--158",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "2",

}

TY - JOUR

T1 - New approach to tumor therapy for inoperable areas of the brain chronic intraparenchymal drug delivery

AU - Solomon, Benjamin

AU - Wu, Q.

AU - Tyler, Betty Mae

AU - Sukay, L.

AU - Raychaudhuri, R.

AU - DiMeco, F.

AU - Clatterbuck, R. E.

AU - Olivi, Alessandro

AU - Guarnieri, M.

PY - 2002/11/1

Y1 - 2002/11/1

N2 - Because the brainstem has little functional redundancy, diffuse lesions have been regarded as inoperable. To determine whether local drug therapy can prolong survival in a rodent model of a tumor in such eloquent tissue, lethal doses of F98 and 9L tumor cells were injected into the brainstems of Fischer 344 rats. Five days after inoculations, 0.5 mg/ml solutions of carboplatin were infused at 1 μl/h for 7 days. Compared to control groups that survived 13-17 days with F98 tumors and 22-23 days with 9L tumors, animals locally infused with 0.1 mg of carboplatin survived 27-30 days (Prob > Chi Sq = 0.0003), and 32 days (Prob > Chi Sq = 0.01), respectively. Measurements of tissue platinum levels at autopsy suggested that infusions distributed pharmacologically relevant levels of carboplatin through a volume of tissue at least 0.5 cm in diameter. The results suggest that chronic low-flow infusions provide a promising approach to therapy for CNS lesions in tissues considered to be inoperable.

AB - Because the brainstem has little functional redundancy, diffuse lesions have been regarded as inoperable. To determine whether local drug therapy can prolong survival in a rodent model of a tumor in such eloquent tissue, lethal doses of F98 and 9L tumor cells were injected into the brainstems of Fischer 344 rats. Five days after inoculations, 0.5 mg/ml solutions of carboplatin were infused at 1 μl/h for 7 days. Compared to control groups that survived 13-17 days with F98 tumors and 22-23 days with 9L tumors, animals locally infused with 0.1 mg of carboplatin survived 27-30 days (Prob > Chi Sq = 0.0003), and 32 days (Prob > Chi Sq = 0.01), respectively. Measurements of tissue platinum levels at autopsy suggested that infusions distributed pharmacologically relevant levels of carboplatin through a volume of tissue at least 0.5 cm in diameter. The results suggest that chronic low-flow infusions provide a promising approach to therapy for CNS lesions in tissues considered to be inoperable.

KW - Brainstem tumors

KW - Carboplatin

KW - CNS cancer

KW - Intracranial drug delivery

KW - Intraparenchymal therapy

UR - http://www.scopus.com/inward/record.url?scp=0036842689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036842689&partnerID=8YFLogxK

U2 - 10.1023/A:1020626419269

DO - 10.1023/A:1020626419269

M3 - Article

VL - 60

SP - 151

EP - 158

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 2

ER -